Cargando…
Colorectal surgery obesity-related morbidity during COVID-19
Tocilizumab, a monoclonal antiinterluekin-6 receptor antibody, has been empirically used in the treatment of cytokine release syndrome associated with severe coronavirus disease 2019 infections. The efficacy and safety of these medications for these patients is unknown. The purpose of this report wa...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Bariatric Surgery. Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346794/ https://www.ncbi.nlm.nih.gov/pubmed/32723601 http://dx.doi.org/10.1016/j.soard.2020.06.011 |